<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00835029</url>
  </required_header>
  <id_info>
    <org_study_id>111111</org_study_id>
    <nct_id>NCT00835029</nct_id>
  </id_info>
  <brief_title>Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis Comparing to Traditional Treatment of Troches</brief_title>
  <official_title>Efficacy of Slow Release Clotrimazole Varnish Treating Denture Stomatitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hadassah Medical Organization</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hadassah Medical Organization</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Oral candidiasis is most frequently found among the elderly .It is accompanied&#xD;
      with oral pain, irritation, burning sensation. In addition, the altered taste sensation may&#xD;
      cause nutrition compromise, which may affect ones diet. Management of superficial oral&#xD;
      Candida is usually achieved by treatment with clotrimazole, a fungi static drug which is&#xD;
      given five times per day with instruction to slowly suck on it with out the dentures.&#xD;
&#xD;
      Working hypothesis and aims: Management of oral candidiasis is feasible. The major&#xD;
      disadvantage of the mode of action now days is the substantively of the drug in the oral&#xD;
      cavity and patient compliance. A sustained release varnish which is easily applied on the&#xD;
      dentures, which also release the anti fungal drug for at least a day, may overcome some of&#xD;
      the pit falls of the treatment applied today.&#xD;
&#xD;
      Based on our past experience, in developing local sustained release varnishes for dental use,&#xD;
      we anticipate that we can also formulate a special anti fungal sustained release varnish&#xD;
      which will fit the special and unique needs of the elderly population.&#xD;
&#xD;
      Methods: Sustained release varnish will be developed in our laboratory. The kinetics of&#xD;
      release (using HPLC) and antifungal activity (Bioassays) will be examined in vitro. The&#xD;
      formulation showing the optimal results will be tested on human subjects with oral&#xD;
      candidiasis. The efficacy of the varnish will be examined clinically (reduction in symptoms),&#xD;
      microbiology (reduction of oral fungal), pharmaceutically (release kinetics in vivo).&#xD;
&#xD;
      Expected results: The clinical out come of one time varnish application will be improved&#xD;
      compared to the five times application of lozenges (used today). The severity of the disease&#xD;
      should decrease and the healing period should be shorten drastically.&#xD;
&#xD;
      Importance: This is a novel pharmaceutical development of a local application of a dental&#xD;
      varnish designed specially to the elderly population&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">February 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Microbial evidence of reduced candida infection</measure>
    <time_frame>one and two weeks after inevention</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Clinical evidence for candida infection</measure>
    <time_frame>One and two weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Oral Candidiasis</condition>
  <condition>Denture Stomatitis</condition>
  <arm_group>
    <arm_group_label>Clotrimazole varnish</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clotrimazole in a slow release varnish treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Clotrimazole troches</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clotrimazole troches 10 mgx5 day for treatment of denture associated candiad infection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clotrimazole varnish</intervention_name>
    <description>Each patient will receive 14 syringes (with no needle, equivalent to 50 mg of Clotrimazole in each one) . The varnish will be applied on a dried denture at the inner side by means of a soft brush and left to dry for 60 sec for 14 days.</description>
    <arm_group_label>Clotrimazole varnish</arm_group_label>
    <other_name>Oralten</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Clotrimazole troches</intervention_name>
    <description>The troche group will be asked to dissolve it in the mouth according to the manufacture instructions five times a day after removal of the denture, for 14 days.</description>
    <arm_group_label>Clotrimazole troches</arm_group_label>
    <other_name>Oralten</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  adults&#xD;
&#xD;
          -  removable denture in mouth&#xD;
&#xD;
          -  diagnosed oral candida&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  allergy to clotrimazole&#xD;
&#xD;
          -  immunosuppressed&#xD;
&#xD;
          -  using other antifungi treatment&#xD;
&#xD;
          -  have an active oral ulcerative disease&#xD;
&#xD;
          -  impaired kidny or live functions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rakefet Czerninski, DMD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hadassah Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hdassah medical Organization,</name>
      <address>
        <city>Jerusalem</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>February 1, 2009</study_first_submitted>
  <study_first_submitted_qc>February 2, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 3, 2009</study_first_posted>
  <last_update_submitted>March 24, 2015</last_update_submitted>
  <last_update_submitted_qc>March 24, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 25, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hadassah Medical Organization</investigator_affiliation>
    <investigator_full_name>Czerninski Rakefet</investigator_full_name>
    <investigator_title>Dr, Oral diseases clinic</investigator_title>
  </responsible_party>
  <keyword>oral</keyword>
  <keyword>candida</keyword>
  <keyword>denture</keyword>
  <keyword>clotrimazole</keyword>
  <keyword>slow releases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Candidiasis</mesh_term>
    <mesh_term>Candidiasis, Oral</mesh_term>
    <mesh_term>Stomatitis</mesh_term>
    <mesh_term>Stomatitis, Denture</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Clotrimazole</mesh_term>
    <mesh_term>Miconazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

